Exact Mass: 476.1511668
Exact Mass Matches: 476.1511668
Found 109 metabolites which its exact mass value is equals to given mass value 476.1511668
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Temocapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain Temocapril belongs to the class of organic compounds known as alpha amino acid esters. These are ester derivatives of alpha amino acids. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Bapta
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].
(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside
arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside
5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester
4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone
(2R,3R)-6-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]pinobanksin 3-acetate
(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside
(10S)-10-C-(4-O-benzoyl-alpha-arabinopyranosyl)-1,8-dihydroxy-3-methylanthracen-9(10H)-one|picramnioside G
Flunarizine 2HCl
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Flunarizine dihydrochloride is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine dihydrochloride is a D2 dopamine receptor antagonist. Flunarizine dihydrochloride shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate
C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]
Cys Glu Glu Pro
C18H28N4O9S (476.15769180000007)
Cys Glu Pro Glu
C18H28N4O9S (476.15769180000007)
Cys His Met Ser
Cys His Ser Met
Cys Met His Ser
Cys Met Ser His
Cys Pro Glu Glu
C18H28N4O9S (476.15769180000007)
Cys Ser His Met
Cys Ser Met His
Asp Asp Met Pro
C18H28N4O9S (476.15769180000007)
Asp Asp Asn Asn
Asp Asp Pro Met
C18H28N4O9S (476.15769180000007)
Asp Met Asp Pro
C18H28N4O9S (476.15769180000007)
Asp Met Pro Asp
C18H28N4O9S (476.15769180000007)
Asp Asn Asp Asn
Asp Asn Asn Asp
Asp Pro Asp Met
C18H28N4O9S (476.15769180000007)
Asp Pro Met Asp
C18H28N4O9S (476.15769180000007)
Glu Cys Glu Pro
C18H28N4O9S (476.15769180000007)
Glu Cys Pro Glu
C18H28N4O9S (476.15769180000007)
Glu Glu Cys Pro
C18H28N4O9S (476.15769180000007)
Glu Glu Pro Cys
C18H28N4O9S (476.15769180000007)
Glu Pro Cys Glu
C18H28N4O9S (476.15769180000007)
Glu Pro Glu Cys
C18H28N4O9S (476.15769180000007)
His Cys Met Ser
His Cys Ser Met
His Met Cys Ser
His Met Ser Cys
His Ser Cys Met
His Ser Met Cys
Met Cys His Ser
Met Cys Ser His
Met Asp Asp Pro
C18H28N4O9S (476.15769180000007)
Met Asp Pro Asp
C18H28N4O9S (476.15769180000007)
Met His Cys Ser
Met His Ser Cys
Met Pro Asp Asp
C18H28N4O9S (476.15769180000007)
Met Ser Cys His
Met Ser His Cys
Asn Asp Asp Asn
Asn Asp Asn Asp
Asn Asn Asp Asp
Pro Cys Glu Glu
C18H28N4O9S (476.15769180000007)
Pro Asp Asp Met
C18H28N4O9S (476.15769180000007)
Pro Asp Met Asp
C18H28N4O9S (476.15769180000007)
Pro Glu Cys Glu
C18H28N4O9S (476.15769180000007)
Pro Glu Glu Cys
C18H28N4O9S (476.15769180000007)
Pro Met Asp Asp
C18H28N4O9S (476.15769180000007)
Ser Cys His Met
Ser Cys Met His
Ser His Cys Met
Ser His Met Cys
Ser Met Cys His
Ser Met His Cys
Feclobuzone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Methotrexate sodium
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents
2-{5-[3-(7-Propyl-3-trifluoromethylbenzo[D]isoxazol-6-yloxy)propoxy]indol-1-YL}ethanoic acid
N-(Cyclopropylmethyl)-4-(methyloxy)-3-({5-[3-(3-pyridinyl)phenyl]-1,3-oxazol-2-YL}amino)benzenesulfonamide
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester
Temocapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
methyl 5-bromo-3-[[2-(4-cyclohexylpiperazin-1-yl)acetyl]amino]-1H-indole-2-carboxylate
Guangsangon L
A member of the class of polyphenols consisting of a methylcyclohexene ring attached to a 2,4-dihydroxyphenyl, 2,4-dihydroxybenzoyl and 2,4-dihydroxybenzaldehyde moieties at positions 5, 4 and 3 respectively. Regarded biogenetically as a Diels-Alder adduct, it is isolated from the stem barks of Morus macroura and exhibits antioxidant activity.
N-(2,4-dimethoxyphenyl)-3-[[2-(2-methoxyphenoxy)-1-oxoethyl]amino]-2-benzofurancarboxamide
methyl 2-[(3-amino-4-carbamoyl-5-cyclohexylimino-2H-thiophene-2-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
(2S,3S,3aR,9bR)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
[(3aR,4R,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4R,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
(4S,4aR,5R,5aR,6S,11aS,12aR)-4-(dimethylamino)-1,5,6,10,11a,12a-hexahydroxy-6-methyl-3,11,12-trioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
BAPTA
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].